Grandfield & Dodd’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-5,837
| Closed | -$296K | – | 187 |
|
|
2017
Q3 | $296K | Sell |
5,837
-317
| -5% | -$16.1K | 0.03% | 160 |
|
|
2017
Q2 | $332K | Sell |
6,154
-180
| -3% | -$9.71K | 0.04% | 154 |
|
|
2017
Q1 | $334K | Sell |
6,334
-159
| -2% | -$8.38K | 0.04% | 151 |
|
|
2016
Q4 | $313K | Sell |
6,493
-1,092
| -14% | -$52.6K | 0.04% | 156 |
|
|
2016
Q3 | $409K | Buy |
7,585
+87
| +1% | +$4.69K | 0.05% | 132 |
|
|
2016
Q2 | $406K | Sell |
7,498
-640
| -8% | -$34.7K | 0.06% | 126 |
|
|
2016
Q1 | $413K | Hold |
8,138
| – | – | 0.06% | 117 |
|
|
2015
Q4 | $410K | Sell |
8,138
-1,775
| -18% | -$89.4K | 0.06% | 119 |
|
|
2015
Q3 | $476K | Sell |
9,913
-177
| -2% | -$8.5K | 0.08% | 108 |
|
|
2015
Q2 | $525K | Buy |
10,090
+41
| +0.4% | +$2.13K | 0.08% | 111 |
|
|
2015
Q1 | $580K | Buy |
10,049
+112
| +1% | +$6.46K | 0.09% | 100 |
|
|
2014
Q4 | $531K | Sell |
9,937
-482
| -5% | -$25.8K | 0.08% | 112 |
|
|
2014
Q3 | $599K | Sell |
10,419
-480
| -4% | -$27.6K | 0.09% | 101 |
|
|
2014
Q2 | $729K | Hold |
10,899
| – | – | 0.11% | 107 |
|
|
2014
Q1 | $728K | Sell |
10,899
-409
| -4% | -$27.3K | 0.11% | 105 |
|
|
2013
Q4 | $755K | Hold |
11,308
| – | – | 0.12% | 98 |
|
|
2013
Q3 | $709K | Hold |
11,308
| – | – | 0.13% | 101 |
|
|
2013
Q2 | $706K | Buy |
+11,308
| New | +$706K | 0.13% | 101 |
|